OPEN END TURBO LONG - SMITH & NEPHEW | Real-time Bid/Ask 10:27:05 06/06/2024 BST | ||
| 1.49 EUR / 1.51 EUR | +13.64% |
|
| Current month | +34.69% | ||
| 1 month | +32.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 1.43 | +8.33% |
| 05/06/24 | 1.32 | +26.92% |
| 04/06/24 | 1.04 | +14.29% |
| 03/06/24 | 0.91 | -7.14% |
| 31/05/24 | 0.98 | -2.97% |
Delayed Quote Börse Stuttgart
Last update June 06, 2024 at 08:59 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2HRZ |
| ISIN | DE000MG2HRZ9 |
| Date issued | 17/04/2024 |
| Strike | 912.8 p |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 0.64 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.47 € |
|---|---|
| Lowest since issue | 0.64 € |
| Spread | 0.02 € |
| Spread % | 1.34% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.13
USD
Average target price
16.45
USD
Spread / Average Target
+25.34%
- Stock Market
- Certificates
- Certificat
